
|Articles|July 1, 2000
The American Journal of Managed Care
- July 2000
- Volume 6
- Issue 7
Clinical and Cost Implications of New Technologies for Cervical Cancer Screening: The Impact of Test Sensitivity
Advertisement
Articles in this issue
over 25 years ago
Improving the Sensitivity of Cervical Cytology: What Are the Issues?over 25 years ago
Why Are Drug Prices Lower in Canada?over 25 years ago
Design and Implementation of an Inpatient Disease Management ProgramNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV
2
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
3
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
4
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
5














































